Auro Laboratories share news, announcements and annual reports
BSE: 530233Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹232.75.
30 Oct: open ₹234.00, high ₹234.00, low ₹225.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹145 Cr2,545th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 30.97
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.13
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.37
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 648
Auro Laboratories share news and announcements
443 announcements, routine notices left out, newest first. Page 5 of 9.
Jul 2021
17 Jul · Shareholding for the Period Ended June 30, 2021
Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click ....15 Jul · Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI Listing Regulations, 2015
14 Jul · Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2021
11 Jun · Board meeting
Meeting on 21 Jun 2021: audited results
May 2021
Apr 2021
20 Apr · Shareholding for the Period Ended March 31, 2021
Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click ....16 Apr · Compliance Certificate Under Regulation 40(9) Of The SEBI Listing Regulations, 2015 For The Half Year Ended March 31, 2021
8 Apr · Compliance Certificate For The Half Year Ended March 31, 2021 Under Regulation 7(3) Of SEBI (LODR), 2015
8 Apr · Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2021
22 Mar · Results
Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Feb 2021
17 Feb · Meeting
3 Feb · Board meeting
Meeting on 11 Feb 2021: quarterly results
Jan 2021
18 Jan · Shareholding for the Period Ended December 31, 2020
Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click ....14 Jan · Legal
Exchange has sought clarification from Auro Laboratories Ltd on January 14, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant ....12 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Nov 2020
6 Nov · Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015
Oct 2020
26 Oct · Board meeting
Meeting on 5 Nov 2020: quarterly results21 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....14 Oct · Compliance Certificate For The Period Ended September 30, 2020 Under Regulation 7(3) Of SEBI (LODR), 2015
14 Oct · Compliance Certificate Under Regulation 40(9) Of The SEBI Listing Regulations, 2015 For The Half Year Ended September 30, 2020
14 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 012 Oct · Legal
Exchange has sought clarification from Auro Laboratories Ltd on October 12, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Sep 2020
29 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Aug 2020
21 Aug · Board meeting
Meeting on 31 Aug 2020: quarterly results and annual general meeting5 Aug · Legal
Exchange has sought clarification from Auro Laboratories Ltd on August 5, 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Jul 2020
17 Jul · Disclosure Of Related Party Transactions Under Regulation 23(9) Of SEBI (LODR) Regulations, 2015
15 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....15 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2020